Terapia Delle Infezioni Dell'Apparato Genitourinario Con Un Nuovo Fluorochinolonico,L'Enoxacina

Abstract

Get full access to this article

View all access options for this article.

References

Kunin

C. M.

: Detection, prevention and management of urinary tract infections. 3^rd ed. Lea & Fehlinger. Philadelphia 1979.

Tolkoff-Rubin

N. E.

, Rubin

R. H.

: Urinary tract infections. In: Contran

R. S.

, Brenner

B. M.

, Stein

J.H.E.

(eds.). Tubulo-interstitial nephropathies. Churchill Livingstone Publ. Co., New York 1983.

Kamaroff

A. L.

: Acute dysuria in women. N. Engl. J. Med., 310; 368 (1984).

Kuono

: In vitro and in vivo antibacterial activity of AT-2266. Antimicrob. Agents Chemother., 24; 78 (1983).

Chartrand

S. A.

: In vitro activity of CI-919 (AT 2266), an oral antipseudomonal compound. Antimicrob. Agents Chemother., 23; 658 (1983).

Wolf

: The clinical pharmacokinetics and tolerance of enoxacin in healty volunteers. J. antimicrob. Chemother., 14; suppl. C, 83 (1984).

Tsuei

S. E.

: Pharmacokinetics and tolerance of enoxacin in healty volunteers administered at a dosage of 400 mg twice daily for 14 days. Ibidem, p. 71.

Yamaguch

: Pharmacokinetics of a new antibacterial agent AT-2266. HI. Plasma levels and urinary excretion of AT-2266 and its metabolites in man. Chemotherapy, 32; suppl. 3, 109 (1984).

Wise

: The pharmacokinetics and tissue penetration of enoxacin and norfloxacin. J. antimicrob. Chemother, 14; suppl. C, 75 (1984).

10.

Hashimoto

: Studies on AT-2266 tissue concentration and clinical efficacy on infectious diseases. Chemotherapy, 32; suppl. 3, 948 (1984).

11.

Maru

, Nakanishi

: The use of AT-2266 in urinary tract infections. Chemotherapy, 32; suppl. 3, 638 (1984).

12.

Miyamoto

: Clinical evaluation of AT-2266 in urinary tract infections. ibidem, p. 645.

13.

Tsuchida

: Clinical study of AT-2266 in urinary tract infections. Ibidem, p. 657.

14.

Kaneko

: Antibacterial activity and clinical evaluation of AT-2266 in complicated urinary tract infections. Ibidem, p. 679.

15.

Saito

: Clinical evaluation of AT-2266 in urinary tract infection. Ibidem, p. 702.

16.

Saito

: Efficacy of AT-2266 for the treatment of acute urethritis. Ibidem, p. 707.

17.

Okada

: Clinical study of AT-2266 in the urological field. Ibidem, p. 714.

18.

Yamamoto

, Miyazaki

: Clinical study of AT-2266 in the treatment of chronic complicated urinary tract infection. Ibidem, p. 728.

19.

Suzuki

: Diffusion of AT-2266, a new oral synthetic antimicrobial agent, into human prostatic fluid and clinical investigations in urinary tract infections. Ibidem, p. 740.

20.

Okasho

: Clinical evaluation of AT-2266 in patients with urinary tract infection. Ibidem, p. 751.

21.

Hara

: Clinical experience of AT-2266 in persistent chronic complicated urinary tract infection. Ibidem, p. 850.

22.

Kamidono

: A double-blind controlled study of AT-2266 and pipemidic acid in complicated urinary tract infection. Ibidem, p. 918.

23.

Hashimoto

: Fundamental and clinical study of AT-2266 in intestinal tract infection. Ibidem, p. 630.

24.

Tsuchiya

: Study of the efficacy of AT-2266 in the treatment of biliary tract infection. Ibidem, p. 995.

25.

Ferrarini

: Studio in cieco semplice di enoxacina verso paromomicina solfato in pazienti con infezioni intestinali. Zambeletti S.p.A. Data en file.

26.

Ida

: Results of a clinical study of AT-2266 in respiratory tract infections. Chemotherapy, 32; suppl. 3, 384 (1984).

27.

Aonuma

: In vitro antibacterial activity of AT-2266 and its therapeutic efficacy on respiratory tract infections. Ibidem, p. 390.

28.

Hayashi

, Abe

: Clinical studies on AT-2266 in the treatment of respiratory tract infections and concentration in sputum and plasma. Ibidem, p. 398.

29.

Kawai

: Clinical evaluation of AT-2266 in the field of respiratory tract infections. Ibidem, p. 421.

30.

Chonabayashi

: Clinical study on AT-2266 in the respiratory tract infection. Ibidem, p. 456.

31.

Odagiri

: A clinical study of AT-2266 in respiratory tract infection. Ibidem, p. 482.

32.

Nakanishi

: Clinical studies on AT-2266 in the treatment of respiratory tract infection. Ibidem, p. 522.

33.

Sawaki

: Clinical study on AT-2266 in chronic lower airway infections. Ibidem, p. 553.

34.

Baba

: Clinical evaluation of AT-2266 in the treatment of infections in the field of otorhinolaryngology. Ibidem, p 1057.

35.

Baba

: A comparative double study of AT-2266 with pipemidic acid in the treatment of suppurative otitis media. Ibidem, p. 1080.

36.

Fujita

: Use of AT-2266 in the treatment of superficial suppurative disease. Ibidem, p. 1037.